Starting April 21, you’ll be asked to log in or sign up for a free account after viewing 10 content pages each month.
Don’t worry—creating an account is quick and easy, and it comes with added benefits! Once logged in, you’ll not only continue accessing the content you already enjoy, but you’ll also unlock exclusive features like interactive donut plots for variant protein effects and variant impacts across the gene.
Stay tuned for these updates, and thank you for being part of our community!
Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | KIT |
Variant | Q556_K558del |
Impact List | deletion |
Protein Effect | gain of function - predicted |
Gene Variant Descriptions | KIT Q556_K558del results in the deletion of three amino acids in the juxtamembrane domain (exon 11) of the Kit protein from amino acids 556 to 558 (PMID: 16226710). Q556_K558del results in constitutive phosphorylation of Kit in culture (PMID: 30094412), and therefore, is predicted to lead to a gain of Kit protein function. |
Associated Drug Resistance | |
Category Variants Paths |
KIT mutant KIT act mut KIT exon 11 del KIT Q556_K558del KIT mutant KIT exon11 KIT exon 11 del KIT Q556_K558del |
Transcript | NM_000222.3 |
gDNA | chr4:g.54727434_54727442delCAGTGGAAG |
cDNA | c.1666_1674delCAGTGGAAG |
Protein | p.Q556_K558delQWK |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
NM_001093772.1 | chr4:g.54727446_54727454delGTTGAGGAG | c.1666_1674delGTTGAGGAG | p.V556_E558delVEE | RefSeq | GRCh38/hg38 |
XM_017008180 | chr4:g.54727446_54727454delGTTGAGGAG | c.1666_1674delGTTGAGGAG | p.V556_E558delVEE | RefSeq | GRCh38/hg38 |
NM_000222 | chr4:g.54727434_54727442delCAGTGGAAG | c.1666_1674delCAGTGGAAG | p.Q556_K558delQWK | RefSeq | GRCh38/hg38 |
NM_001385286.1 | chr4:g.54727446_54727454delGTTGAGGAG | c.1666_1674delGTTGAGGAG | p.V556_E558delVEE | RefSeq | GRCh38/hg38 |
NM_000222.2 | chr4:g.54727434_54727442delCAGTGGAAG | c.1666_1674delCAGTGGAAG | p.Q556_K558delQWK | RefSeq | GRCh38/hg38 |
NM_001093772.2 | chr4:g.54727446_54727454delGTTGAGGAG | c.1666_1674delGTTGAGGAG | p.V556_E558delVEE | RefSeq | GRCh38/hg38 |
XM_017008178 | chr4:g.54727434_54727442delCAGTGGAAG | c.1666_1674delCAGTGGAAG | p.Q556_K558delQWK | RefSeq | GRCh38/hg38 |
XM_005265742.3 | chr4:g.54727444_54727452delTTGTTGAGG | c.1667_1675delTTGTTGAGG | p.V556_E558delVVE | RefSeq | GRCh38/hg38 |
NM_000222.3 | chr4:g.54727434_54727442delCAGTGGAAG | c.1666_1674delCAGTGGAAG | p.Q556_K558delQWK | RefSeq | GRCh38/hg38 |
NM_001385290.1 | chr4:g.54727431_54727439delGTACAGTGG | c.1666_1674delGTACAGTGG | p.V556_W558delVQW | RefSeq | GRCh38/hg38 |
NM_001093772 | chr4:g.54727446_54727454delGTTGAGGAG | c.1666_1674delGTTGAGGAG | p.V556_E558delVEE | RefSeq | GRCh38/hg38 |
XM_017008178.1 | chr4:g.54727434_54727442delCAGTGGAAG | c.1666_1674delCAGTGGAAG | p.Q556_K558delQWK | RefSeq | GRCh38/hg38 |
NM_001385285.1 | chr4:g.54727434_54727442delCAGTGGAAG | c.1666_1674delCAGTGGAAG | p.Q556_K558delQWK | RefSeq | GRCh38/hg38 |
XM_005265742 | chr4:g.54727444_54727452delTTGTTGAGG | c.1667_1675delTTGTTGAGG | p.V556_E558delVVE | RefSeq | GRCh38/hg38 |
XM_005265740 | chr4:g.54727431_54727439delGTACAGTGG | c.1666_1674delGTACAGTGG | p.V556_W558delVQW | RefSeq | GRCh38/hg38 |
XM_005265741.1 | chr4:g.54727431_54727439delGTACAGTGG | c.1666_1674delGTACAGTGG | p.V556_W558delVQW | RefSeq | GRCh38/hg38 |
NM_001385284.1 | chr4:g.54727431_54727439delGTACAGTGG | c.1666_1674delGTACAGTGG | p.V556_W558delVQW | RefSeq | GRCh38/hg38 |
XM_005265741 | chr4:g.54727431_54727439delGTACAGTGG | c.1666_1674delGTACAGTGG | p.V556_W558delVQW | RefSeq | GRCh38/hg38 |
XM_005265740.1 | chr4:g.54727431_54727439delGTACAGTGG | c.1666_1674delGTACAGTGG | p.V556_W558delVQW | RefSeq | GRCh38/hg38 |
NM_001385292.1 | chr4:g.54727444_54727452delTTGTTGAGG | c.1667_1675delTTGTTGAGG | p.V556_E558delVVE | RefSeq | GRCh38/hg38 |
NM_001385288.1 | chr4:g.54727444_54727452delTTGTTGAGG | c.1667_1675delTTGTTGAGG | p.V556_E558delVVE | RefSeq | GRCh38/hg38 |
XM_017008179 | chr4:g.54727444_54727452delTTGTTGAGG | c.1667_1675delTTGTTGAGG | p.V556_E558delVVE | RefSeq | GRCh38/hg38 |
XM_017008179.1 | chr4:g.54727444_54727452delTTGTTGAGG | c.1667_1675delTTGTTGAGG | p.V556_E558delVVE | RefSeq | GRCh38/hg38 |
XM_017008180.1 | chr4:g.54727446_54727454delGTTGAGGAG | c.1666_1674delGTTGAGGAG | p.V556_E558delVEE | RefSeq | GRCh38/hg38 |
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|